sitaxsentan Size:Solid 10 mg (2015) J Med Chem

(2015) J Med Chem

The potency of AZD9496 with IC50 of 0

cell division signals and structures (mitotic spindles) as well as some elements of intracellular transport

methyl (1R

Heterogeneous ceramide distributions alter spatially resolved growth of Staphylococcus aureus on human stratum corneum

sitaxsentan Size:Solid 10 mg (2015) J Med ChemSitaxentan, also known as TBC 11251 and IPI 1040, is a medication for the treatment of pulmonary arterial hypertension (PAH). It was marketed as Thelin. In 2010, Pfizer voluntarily removed sitaxentan from the market due to concerns about liver toxicity. Sitaxentan is a small molecule that blocks the action of endothelin (ET) on the endothelin A (ETA) receptor selectively (by a factor of 6000 compared with the ETB). Product information CAS Number: